Catalonia: A European leader in clinical trials
International Clinical Trials Day has been on May 20 each year since 2005 to commemorate the day that James Lind began his famous trial and help to drwan attention to the importance of research in healthcare. Catalonia has become one of the regions conducting the most clinical trials globally, in the recent years.
Since 2001, the number of clinical trials carried out in Catalonia have grown consistently year after year (excluding 2020, when clinical trials were delayed due to the Covid-19 pandemic, which had a slight effect on the number of trials initiated on that year). However, the BioRegion also outperformed in Covid-19 clinical trials and ranked 6th position in Europe.
A first-class healthcare system, with top-notch hospitals and internationally renowned healthcare professionals, are the main factors explaining why Catalonia has emerged as a prime destination for clinical trials in the world. In fact, the most important international pharmaceutical companies, including Novartis, Roche, MSD, AstraZeneca, Janssen, GSK, Boehringer Ingelheim, Bayer, Bristol-Myers Squibb, Gilead, Pfizer, AbbVie and Sanofi, are running their trials in Catalonia.
Catalonia is one of the world‘s top 10 sites in terms of participation in clinical trials underway, only outranked by large countries such as the United States, Canada, France, United Kingdom, Germany, Spain and Italy. Moreover, Catalonia excels in conducting clinical trials in a wide range of therapeutic areas, as shown in the figure below:
In addition, Catalonia excels in the performance of clinical trials in a wide variety of therapeutic areas, as can be seen in the figure below:
4th Annual Summit for Clinical Trials Operations Executives Europe (SCOPE Europe) to be held in Barcelona in October
CHI SCOPE Europe is organized by Cambriadge Healthtech Institute (CHI) and will be held form on 5 – 6 October, 2021 at the InterContinental Barcelona – Fira Center, in the city of Barcelona The conference will be hybrid: virtual and face-to-face.
It will be an opportunity for leaders from large, mid-sized, and small pharma, along with specialty pharma, biotech, vendor companies, and academic research centers to come together to share best practices and discuss the new era of analytics-driven and patient-centric trials.
The event features two keynote sessions, interactive breakout groups, roundtable discussions and exclusive exhibits and networking. It will be a great opportunity to exchange ideas and discuss the new era of analytics-driven and patient-centric trials.
Biocat is offering a discount off any kind of conference pass by using the code Biocat20 during the registration process. Don’t miss it!
Buy your pass and register here!
